# A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

> **NCT00196339** · PHASE2 · COMPLETED · sponsor: **Duramed Research** · enrollment: 315 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Cyproterone acetate 5
- **DRUG:** Placebo
- **DRUG:** Cyproterone acetate 15
- **DRUG:** Cyproterone acetate 25

## Key facts

- **NCT ID:** NCT00196339
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2016-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196339, "A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00196339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*